Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 354

1.

Dynamics of the nucleoside diphosphate kinase protein DYNAMO2 correlates with the changes in the global GTP level during the cell cycle of Cyanidioschyzon merolae.

Imoto Y, Abe Y, Okumoto K, Ohnuma M, Kuroiwa H, Kuroiwa T, Fujiki Y.

Proc Jpn Acad Ser B Phys Biol Sci. 2019;95(2):75-85. doi: 10.2183/pjab.95.007.

2.

An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis.

Koike Y, Fujiki Y, Higuchi M, Fukuchi R, Kuwatsuka S, Murota H.

JAAD Case Rep. 2019 Jan 25;5(2):150-152. doi: 10.1016/j.jdcr.2018.11.016. eCollection 2019 Feb. No abstract available.

3.

Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.

Tokai N, Yoshida S, Kotani T, Yoshikawa A, Kimura Y, Fujiki Y, Matsumura Y, Takeuchi T, Makino S, Arawaka S.

PLoS One. 2019 Jan 30;14(1):e0211750. doi: 10.1371/journal.pone.0211750. eCollection 2019.

4.

Efficacy of Thyrotropin-Releasing Hormone Analog for Protracted Disturbance of Consciousness due to Aneurysmal Subarachnoid Hemorrhage.

Shibata A, Matano F, Fujiki Y, Mizunari T, Murai Y, Yokota H, Morita A.

J Stroke Cerebrovasc Dis. 2019 Jan 16. pii: S1052-3057(18)30736-5. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.036. [Epub ahead of print]

PMID:
30660483
5.

Peroxisome biogenesis deficiency attenuates the BDNF-TrkB pathway-mediated development of the cerebellum.

Abe Y, Honsho M, Itoh R, Kawaguchi R, Fujitani M, Fujiwara K, Hirokane M, Matsuzaki T, Nakayama K, Ohgi R, Marutani T, Nakayama KI, Yamashita T, Fujiki Y.

Life Sci Alliance. 2018 Dec 3;1(6):e201800062. doi: 10.26508/lsa.201800062. eCollection 2018 Dec.

6.

A newly identified mutation in the PEX26 gene is associated with a milder form of Zellweger spectrum disorder.

Tanaka AJ, Okumoto K, Tamura S, Abe Y, Hirsch Y, Deng L, Ekstein J, Chung WK, Fujiki Y.

Cold Spring Harb Mol Case Stud. 2019 Feb 1;5(1). pii: a003483. doi: 10.1101/mcs.a003483. Print 2019 Feb.

7.

Onsite GTP fuelling via DYNAMO1 drives division of mitochondria and peroxisomes.

Imoto Y, Abe Y, Honsho M, Okumoto K, Ohnuma M, Kuroiwa H, Kuroiwa T, Fujiki Y.

Nat Commun. 2018 Nov 6;9(1):4634. doi: 10.1038/s41467-018-07009-z.

8.

Efficacy and safety of oral high-trough level tacrolimus in acute/subacute interstitial pneumonia with dermatomyositis.

Suzuka T, Kotani T, Takeuchi T, Fujiki Y, Hata K, Yoshida S, Shoda T, Makino S, Arawaka S.

Int J Rheum Dis. 2019 Feb;22(2):303-313. doi: 10.1111/1756-185X.13414. Epub 2018 Nov 5.

PMID:
30398034
9.

Cell Death or Survival Against Oxidative Stress.

Miyata N, Okumoto K, Fujiki Y.

Subcell Biochem. 2018;89:463-471. doi: 10.1007/978-981-13-2233-4_20.

PMID:
30378036
10.

Identification of Peroxisomal Protein Complexes with PTS Receptors, Pex5 and Pex7, in Mammalian Cells.

Okumoto K, Miyata N, Fujiki Y.

Subcell Biochem. 2018;89:287-298. doi: 10.1007/978-981-13-2233-4_12.

PMID:
30378028
11.

The cytosolic peroxisome-targeting signal (PTS)-receptors, Pex7p and Pex5pL, are sufficient to transport PTS2 proteins to peroxisomes.

Mukai S, Matsuzaki T, Fujiki Y.

Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):441-449. doi: 10.1016/j.bbamcr.2018.10.006. Epub 2018 Oct 5.

PMID:
30296498
12.

A newly isolated Pex7-binding, atypical PTS2 protein P7BP2 is a novel dynein-type AAA+ protein.

Niwa H, Miyauchi-Nanri Y, Okumoto K, Mukai S, Noi K, Ogura T, Fujiki Y.

J Biochem. 2018 Dec 1;164(6):437-447. doi: 10.1093/jb/mvy073.

PMID:
30204880
13.

Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling.

Goto-Yamaguchi L, Yamamoto-Ibusuki M, Yamamoto Y, Fujiki Y, Tomiguchi M, Sueta A, Takeshita T, Iwase H.

Breast Cancer Res Treat. 2018 Nov;172(2):353-362. doi: 10.1007/s10549-018-4933-5. Epub 2018 Aug 27.

PMID:
30151737
14.

Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.

Tokai N, Yoshida S, Kotani T, Yoshikawa A, Kimura Y, Fujiki Y, Matsumura Y, Takeuchi T, Makino S, Arawaka S.

PLoS One. 2018 Aug 23;13(8):e0202601. doi: 10.1371/journal.pone.0202601. eCollection 2018. Erratum in: PLoS One. 2019 Jan 30;14(1):e0211750.

15.

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer.

Fujiki Y, Yamamoto Y, Sueta A, Yamamoto-Ibusuki M, Goto-Yamaguchi L, Tomiguchi M, Takeshita T, Iwase H.

Oncotarget. 2018 Jul 17;9(55):30513-30526. doi: 10.18632/oncotarget.25495. eCollection 2018 Jul 17.

16.

General formulation of long-range degree correlations in complex networks.

Fujiki Y, Takaguchi T, Yakubo K.

Phys Rev E. 2018 Jun;97(6-1):062308. doi: 10.1103/PhysRevE.97.062308.

PMID:
30011590
17.

Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.

Ishida T, Yoshida S, Kimura Y, Fujiki Y, Kotani T, Takeuchi T, Makino S, Arawaka S.

Lupus. 2018 Sep;27(10):1636-1643. doi: 10.1177/0961203318784649. Epub 2018 Jun 28.

PMID:
29954283
18.

Efficacy and safety of combination therapy with prednisolone and oral tacrolimus for progressive interstitial pneumonia with systemic sclerosis: A retrospective study.

Konma J, Kotani T, Shoda T, Suzuka T, Fujiki Y, Nagai K, Hata K, Yoshida S, Takeuchi T, Makino S, Arawaka S.

Mod Rheumatol. 2018 Nov;28(6):1009-1015. doi: 10.1080/14397595.2018.1441658. Epub 2018 Mar 2.

PMID:
29442534
19.

New splicing variants of mitochondrial Rho GTPase-1 (Miro1) transport peroxisomes.

Okumoto K, Ono T, Toyama R, Shimomura A, Nagata A, Fujiki Y.

J Cell Biol. 2018 Feb 5;217(2):619-633. doi: 10.1083/jcb.201708122. Epub 2017 Dec 8.

20.

Serum glucose/potassium ratio as a clinical risk factor for aneurysmal subarachnoid hemorrhage.

Fujiki Y, Matano F, Mizunari T, Murai Y, Tateyama K, Koketsu K, Kubota A, Kobayashi S, Yokota H, Morita A.

J Neurosurg. 2018 Oct;129(4):870-875. doi: 10.3171/2017.5.JNS162799. Epub 2017 Nov 17.

PMID:
29148905
21.

Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature.

Matsuda S, Yoshida S, Fujiki Y, Satomi H, Takeuchi T, Hirose Y, Makino S, Arawaka S.

Rheumatol Int. 2018 Apr;38(4):689-696. doi: 10.1007/s00296-017-3875-2. Epub 2017 Nov 10. Review.

PMID:
29127573
22.

Subarachnoid Aneurysmal Hemorrhage Associated with Coarctation of the Aorta: Case Report and Review of the Literature.

Nakae R, Fujiki Y, Yokobori S, Naoe Y, Yokota H.

J Nippon Med Sch. 2017;84(4):186-192. doi: 10.1272/jnms.84.186. Review.

23.

Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis.

Hisanaga J, Kotani T, Fujiki Y, Yoshida S, Takeuchi T, Makino S.

Int J Rheum Dis. 2017 Dec;20(12):2182-2185. doi: 10.1111/1756-185X.13136. Epub 2017 Jul 27. No abstract available.

PMID:
28752606
24.

Plasmalogen homeostasis - regulation of plasmalogen biosynthesis and its physiological consequence in mammals.

Honsho M, Fujiki Y.

FEBS Lett. 2017 Sep;591(18):2720-2729. doi: 10.1002/1873-3468.12743. Epub 2017 Jul 28. Review.

25.

Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study.

Yoshikawa A, Yoshida S, Kimura Y, Tokai N, Fujiki Y, Kotani T, Matsumura Y, Takeuchi T, Makino S.

Mod Rheumatol. 2018 Mar;28(2):227-234. doi: 10.1080/14397595.2017.1336865. Epub 2017 Jun 23.

PMID:
28644744
26.

BAK regulates catalase release from peroxisomes.

Fujiki Y, Miyata N, Mukai S, Okumoto K, Cheng EH.

Mol Cell Oncol. 2017 Mar 17;4(3):e1306610. doi: 10.1080/23723556.2017.1306610. eCollection 2017.

27.

Quantitative Comparison of the Intraoperative Utility of Indocyanine Green and Fluorescein Videoangiographies in Cerebrovascular Surgery.

Matano F, Mizunari T, Murai Y, Kubota A, Fujiki Y, Kobayashi S, Morita A.

Oper Neurosurg (Hagerstown). 2017 Jun 1;13(3):361-366. doi: 10.1093/ons/opw020.

PMID:
28521359
28.

Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients.

Fujiki Y, Kotani T, Isoda K, Ishida T, Shoda T, Yoshida S, Takeuchi T, Makino S.

Mod Rheumatol. 2018 Jan;28(1):133-140. doi: 10.1080/14397595.2017.1318468. Epub 2017 May 11.

PMID:
28490218
29.

Generation of Peroxisome-Deficient Somatic Animal Cell Mutants.

Okumoto K, Fujiki Y.

Methods Mol Biol. 2017;1595:319-327. doi: 10.1007/978-1-4939-6937-1_29.

PMID:
28409474
30.

Experimental Systems to Study Yeast Pexophagy.

Yamashita SI, Oku M, Sakai Y, Fujiki Y.

Methods Mol Biol. 2017;1595:249-255. doi: 10.1007/978-1-4939-6937-1_24.

PMID:
28409469
31.

Assessing Pexophagy in Mammalian Cells.

Yamashita SI, Fujiki Y.

Methods Mol Biol. 2017;1595:243-248. doi: 10.1007/978-1-4939-6937-1_23.

PMID:
28409468
32.

Peroxisomal Membrane and Matrix Protein Import Using a Semi-Intact Mammalian Cell System.

Okumoto K, Honsho M, Liu Y, Fujiki Y.

Methods Mol Biol. 2017;1595:213-219. doi: 10.1007/978-1-4939-6937-1_20.

PMID:
28409465
33.

In Vitro PMP Import Analysis Using Cell-Free Synthesized PMP and Isolated Peroxisomes.

Liu Y, Honsho M, Fujiki Y.

Methods Mol Biol. 2017;1595:207-212. doi: 10.1007/978-1-4939-6937-1_19.

PMID:
28409464
34.

Blue Native PAGE: Applications to Study Peroxisome Biogenesis.

Okumoto K, Tamura S, Fujiki Y.

Methods Mol Biol. 2017;1595:197-205. doi: 10.1007/978-1-4939-6937-1_18.

PMID:
28409463
35.

Analysis of Plasmalogen Synthesis in Cultured Cells.

Honsho M, Fujiki Y.

Methods Mol Biol. 2017;1595:55-61. doi: 10.1007/978-1-4939-6937-1_6.

PMID:
28409451
36.

Peroxisome biogenesis: a novel inducible PEX19 splicing variant is involved in early stages of peroxisome proliferation.

Kinoshita N, Matsuura A, Fujiki Y.

J Biochem. 2017 Mar 1;161(3):297-308. doi: 10.1093/jb/mvw075.

PMID:
28391327
37.

Reduction of Ether-Type Glycerophospholipids, Plasmalogens, by NF-κB Signal Leading to Microglial Activation.

Hossain MS, Abe Y, Ali F, Youssef M, Honsho M, Fujiki Y, Katafuchi T.

J Neurosci. 2017 Apr 12;37(15):4074-4092. doi: 10.1523/JNEUROSCI.3941-15.2017. Epub 2017 Mar 14.

38.
39.

The VDAC2-BAK axis regulates peroxisomal membrane permeability.

Hosoi KI, Miyata N, Mukai S, Furuki S, Okumoto K, Cheng EH, Fujiki Y.

J Cell Biol. 2017 Mar 6;216(3):709-722. doi: 10.1083/jcb.201605002. Epub 2017 Feb 7.

40.

Localization of Protein Kinase NDR2 to Peroxisomes and Its Role in Ciliogenesis.

Abe S, Nagai T, Masukawa M, Okumoto K, Homma Y, Fujiki Y, Mizuno K.

J Biol Chem. 2017 Mar 10;292(10):4089-4098. doi: 10.1074/jbc.M117.775916. Epub 2017 Jan 25.

41.

Defining the dynamin-based ring organizing center on the peroxisome-dividing machinery isolated from Cyanidioschyzon merolae.

Imoto Y, Abe Y, Okumoto K, Honsho M, Kuroiwa H, Kuroiwa T, Fujiki Y.

J Cell Sci. 2017 Mar 1;130(5):853-867. doi: 10.1242/jcs.199182. Epub 2017 Jan 23.

42.

Retrograde suction decompression of a large internal carotid aneurysm using a balloon guide catheter combined with a blood-returning circuit and STA-MCA bypass: a technical note.

Matano F, Mizunari T, Kominami S, Suzuki M, Fujiki Y, Kubota A, Kobayashi S, Murai Y, Morita A.

Neurosurg Rev. 2017 Apr;40(2):351-355. doi: 10.1007/s10143-016-0808-6. Epub 2016 Dec 16.

PMID:
27987034
43.

Peroxisome biogenesis and human peroxisome-deficiency disorders.

Fujiki Y.

Proc Jpn Acad Ser B Phys Biol Sci. 2016;92(10):463-477. Review.

44.

Functional identification of AtAVT3, a family of vacuolar amino acid transporters, in Arabidopsis.

Fujiki Y, Teshima H, Kashiwao S, Kawano-Kawada M, Ohsumi Y, Kakinuma Y, Sekito T.

FEBS Lett. 2017 Jan;591(1):5-15. doi: 10.1002/1873-3468.12507. Epub 2016 Dec 19.

45.

Deficiency of a Retinal Dystrophy Protein, Acyl-CoA Binding Domain-containing 5 (ACBD5), Impairs Peroxisomal β-Oxidation of Very-long-chain Fatty Acids.

Yagita Y, Shinohara K, Abe Y, Nakagawa K, Al-Owain M, Alkuraya FS, Fujiki Y.

J Biol Chem. 2017 Jan 13;292(2):691-705. doi: 10.1074/jbc.M116.760090. Epub 2016 Nov 29.

46.

Hodge Decomposition of Information Flow on Small-World Networks.

Haruna T, Fujiki Y.

Front Neural Circuits. 2016 Sep 28;10:77. eCollection 2016.

47.

Asymptomatic rheumatoid meningitis revealed by magnetic resonance imaging, followed by systemic rheumatic vasculitis: A case report and a review of the literature.

Matsuda S, Yoshida S, Takeuchi T, Fujiki Y, Yoshikawa A, Makino S.

Mod Rheumatol. 2016 Sep 23:1-7. [Epub ahead of print]

PMID:
27659704
48.

Radiological diagnosis of gas gangrene in a fetus at term.

Abe K, Hamada H, Fujiki Y, Iiba M, Tenjimbayashi Y, Yoshikawa H.

Taiwan J Obstet Gynecol. 2016 Aug;55(4):582-4. doi: 10.1016/j.tjog.2016.06.006.

49.

Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.

Tomiguchi M, Yamamoto Y, Yamamoto-Ibusuki M, Goto-Yamaguchi L, Fujiki Y, Fujiwara S, Sueta A, Hayashi M, Takeshita T, Inao T, Iwase H.

Cancer Sci. 2016 Apr;107(4):491-8. doi: 10.1111/cas.12897. Epub 2016 Mar 28.

50.

Assembly of Peroxisomal Membrane Proteins via the Direct Pex19p-Pex3p Pathway.

Liu Y, Yagita Y, Fujiki Y.

Traffic. 2016 Apr;17(4):433-55. doi: 10.1111/tra.12376. Epub 2016 Feb 23.

Supplemental Content

Loading ...
Support Center